Smith Drug Company and Burlington Drug Company recently joined with more than 115 other health care groups to endorse bipartisan legislation that would prohibit pharmacy benefit managers from adding retroactive charges on Medicare Part D prescription drugs.

The effect of those fees is to raise costs for seniors, taxpayers and pharmacies.

SPARTANBURG, S.C. – August 22 2016; Smith Drug Company welcomed Claire Brandewie, Legislative Assistant and Danielle Gibbs, Regional Director both aides to Senator Tim Scott on Thursday, August 18, 2016. President Jeff Foreman, R.Ph. took them on a tour of the 250,000 square foot distribution center located in Spartanburg, SC. Impressed with the technology and automation behind this operation, it was clear to the visitors that the highest of efficiencies are in place to ensure the right product(s) are delivered at the right time and to the right destination (customer).

The Centers for Medicare and Medicaid Services' proposed Part D rule may sound like typical inside the Beltway speak, but it has the potential to dramatically affect your business and your patients.

This coming Wednesday there will be a Hearing by the Energy and Commerce Subcommittee on Health on the proposed rule. If your Congressman is on this committee not only do you need to reach out to him or her but you need to tell 10 of your colleagues and patients to do the same.

HDMA members went to Capitol Hill on February 5 to educate members of Congress on the role of pharmaceutical distributors in combatting prescription drug abuse. Participants of HDMA’s 2014 Hill Day shared with legislators and staff that HDMA and its primary pharmaceutical distributor members are committed to being part of the solution and working collaboratively to address the country’s prescription drug abuse epidemic.